Oral Chinese Patent Medicine Combined With Oxaliplatin-Based Chemotherapy Regimen for the Treatment of Colorectal Cancer: A Network Meta-Analysis
Objective: To access the comparative effectiveness and safety of different oral Chinese patent medicine (OCPM) versus oxaliplatin-based chemotherapy regimen (C) alone for colorectal cancer (CRC) through network meta-analysis (NMA). Methods: Several electronic databases were searched for randomized c...
Guardado en:
Autores principales: | Mo Tang PhD Student, Bin He Doctor, Jiawei Zhai Master, Lei Wang PhD Student |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/04521a5b15b745b0b8b45078ebadc178 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pediatric Inflammatory Bowel Disease Associated With Celiac Disease: A Retrospective Study in a Tertiary Care Hospital in Saudi Arabia
por: Mamdouh Qadi Medical Student, et al.
Publicado: (2021) -
Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study
por: Jie Zhang PhD, et al.
Publicado: (2021) -
Addressing Disparities for Intersectional BIPOC Communities: The Hood Medicine Initiative Case Study
por: Emily Hotez, PhD, et al.
Publicado: (2021) -
Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients
por: Filippo Massa, PhD, et al.
Publicado: (2021) -
Allergic diseases in infancy II–oral tolerance and its failure
por: Mathias Hornef, MD, et al.
Publicado: (2021)